Literature DB >> 10581537

Radiofrequency electromagnetic fields have no effect on the in vivo proliferation of the 9L brain tumor.

R Higashikubo1, V O Culbreth, D R Spitz, M C LaRegina, W F Pickard, W L Straube, E G Moros, J L Roti.   

Abstract

The intracranial 9L tumor model was used to determine if exposure to a radiofrequency (RF) electromagnetic field similar to those used in cellular telephone has any effects on the growth of a central nervous system tumor. Fischer 344 rats implanted with different numbers of 9L gliosarcoma cells were exposed to 835.62 MHz frequency-modulated continuous wave (FMCW) or 847.74 MHz code division multiple access (CDMA) RF field with nominal slot-average specific absorption rates in the brain of 0.75 +/- 0.25 W/kg. The animals were exposed to the RF field for 4 h a day, 5 days a week starting 4 weeks prior to and up to 150 days after the implantation of tumor cells. Among sham-exposed animals injected with 2 to 10 viable cells (group 1), the median survival was 70 days, with 27% of the animals surviving at 150 days. The median survival length and final survival fraction for animals injected with 11 to 36 viable cells (group 2) were 52 days and 14%, respectively, while the values for those injected with 37 to 100 cells (group 3) were 45 days and 0%. The animals exposed to CDMA or FMCW had similar survival parameters, and the statistical comparison of the survival curves for each of the groups 1, 2 and 3 showed no significant differences compared to sham-exposed controls.

Entities:  

Mesh:

Year:  1999        PMID: 10581537

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  Mobile phone use and cancer.

Authors:  M Kundi
Journal:  Occup Environ Med       Date:  2004-06       Impact factor: 4.402

2.  Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats.

Authors:  Nihal S Ouadah; Anthony Lecomte; Franck Robidel; Ann Olsson; Isabelle Deltour; Joachim Schüz; Kelly Blazy; Anne-Sophie Villégier
Journal:  J Neurooncol       Date:  2018-11-12       Impact factor: 4.130

Review 3.  Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.

Authors:  Gary W Arendash
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.